Abstract
Diffusion Magnetic Resonance Imaging (dMRI) sensitises the MRI signal to spin motion. This includes Brownian diffusion, but also flow across intricate networks of capillaries. This effect, the intra-voxel incoherent motion (IVIM), enables microvasculature characterisation with dMRI, through metrics such as the vascular signal fraction fV or Apparent Diffusion Coefficient (ADC) D*. The IVIM metrics, while sensitive to perfusion, are in general protocol-dependent, and their interpretation can change depending on the flow regime spins experience during the dMRI measurements (e.g., diffusive vs ballistic), which is in general not known — facts that hamper their clinical utility. Innovative vascular dMRI models are needed to enable the in vivo calculation of biologically meaningful markers of capillary flow. These could have relevant applications in cancer, for instance assessing responses to anti-angiogenic therapies targeting tumor vessels. This paper tackles this need by introducing SpinFlowSim, an open-source simulator of dMRI signals arising from blood flow within pipe networks. SpinFlowSim, tailored for the laminar flow patterns in capillaries, enables the synthesis of highly-realistic microvascular dMRI signals, given networks reconstructed from histology. We showcase the simulator by generating synthetic signals for 15 networks, reconstructed from liver biopsies, and containing cancerous and non-cancerous tissue. Signals exhibit com-plex, non-mono-exponential behaviours, pointing towards the co-existence of different flow regimes within the same network, and diffusion time dependence. We also demonstrate the potential utility of SpinFlowSim by devising a strategy for microvascular property mapping informed by the synthetic signals, focussing on the quantification of blood velocity distribution moments, and of an apparent network branching index. These were estimated in silico and in vivo, in healthy volunteers and in 13 cancer patients, scanned at 1.5T. In conclusion, realistic flow simulations, as those enabled by SpinFlowSim, may play a key role in the development of the next-generation of dMRI methods for microvascular mapping, with immediate applications in oncology.
Competing Interest Statement
This study has received support by AstraZeneca. K.B. was a researcher at VHIO (Barcelona, Spain), and is now an employee of AstraZeneca (Barcelona, Spain). AstraZeneca was not involved in the acquisition and analysis of the data, interpretation of the results, or the decision to submit this article for publication in its current form.
Funding Statement
VHIO would like to acknowledge: the State Agency for Research (Agencia Estatal de Investigacion) for the financial support as a Center of Excellence Severo Ochoa (CEX2020-001024-S/AEI/10.13039/501100011033), the Cellex Founda tion for providing research facilities and equipment and the CERCA Programme from the Generalitat de Catalunya for their support on this research. This research has been supported by PREdICT, sponsored by AstraZeneca. This study has been co-funded by the European Regional Development Fund/European Social Fund 'A way to make Europe' (to R.P.L.), and by the Comprehensive Program of Cancer Immunotherapy and Immunology (CAIMI), funded by the Banco Bilbao Vizcaya Argentaria Foundation Foundation (FBBVA, grant 89/2017). R.P.L. is supported by the "la Caixa" Foundation CaixaResearch Advanced Oncology Research Program, the Prostate Cancer Foundation (18YOUN19), a CRIS Foundation Talent Award (TALENT19-05), the FERO Foundation through the XVIII Fero Fellowship for Oncological Research, the Instituto de Salud Carlos III-Investigacion en Salud (PI18/01395 and PI21/01019), the Asociacion Espanola Contra el Cancer (AECC) (PRYCO211023SERR) and the Generalitat de Catalunya Agency for Management of University and Research Grants of Catalonia (AGAUR) (2023PROD00178). The project that gave rise to these results received the support of a fellowship from "la Caixa" Foundation (ID 100010434). The fellowship code is "LCF/BQ/PR22/11920010" (funding F.G., A.V., and A.G.). This research has received support from the Beatriu de Pinos Postdoctoral Program from the Secretariat of Universities and Research of the Department of Business and Knowledge of the Government of Catalonia, and the support from the Marie Sklodowska-Curie COFUND program (BP3, contract number 801370; reference 2019 BP 00182) of the H2020 program (to K.B.). M.P. is supported by the UKRI Future Leaders Fellowship MR/T020296/2. A.G. is supported by a Severo Ochoa PhD fellowship (PRE2022-102586). The authors are thankful to the Vall d'Hebron Radiology department and to the ASCIRES CETIR clinical team for their assistance with MRI acquisitions, and to the GE/Siemens clinical scientists for their support with diffusion sequence characterisation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study in cancer patients and healthy volunteers was approved by the Vall d'Hebron University Hospital Ethics committee (PR(AG)29/2020 and PR(IDI)109/2022), Barcelona, Spain. Informed written consent to participate in the study was obtained.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵** joint senior (last) authors
Data Availability
SpinFlowSim is made freely available as a GitHub repository at the permanent address: https://github.com/radiomicsgroup/SpinFlowSim. The repository includes the 15 vascular networks presented in this study that can be used to generate synthetic signals to inform model fitting. The code for simulation-informed fitting is freely available as part of BodyMRITools at the permanent address: https://github.com/fragrussu/bodymritools (script mri2micro dictml.py). The in vivo human data cannot be made freely available at this stage due to ethical restrictions.
